Selected research
Industry Growth & Trends
Global Finasteride Industry Growth and Trends Forecast to 2032
Market perspective
The global Finasteride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Finasteride include Teva Pharmaceuticals, Sandoz, Shandong Renhetang Pharmaceutical, Merck, Zhejiang CONBA Pharmaceutical, Henan Topfond, Guangdong Eashu Pharmacetical, RelonChem and Dr. Reddy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Finasteride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Finasteride market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Finasteride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Finasteride.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Finasteride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Finasteride Market by Company
Teva Pharmaceuticals
Sandoz
Shandong Renhetang Pharmaceutical
Merck
Zhejiang CONBA Pharmaceutical
Henan Topfond
Guangdong Eashu Pharmacetical
RelonChem
Dr. Reddy
Cipla
Actavis
Accord Pharmaceuticals
Finasteride Segment by Type
1mg Tablet
5mg Tablet
Finasteride Segment by Application
Medical Uses
Application 2
Finasteride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Finasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Finasteride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg Tablet
- 5mg Tablet
Applications
- Medical Uses
- Application 2
Companies covered
- Teva Pharmaceuticals
- Sandoz
- Shandong Renhetang Pharmaceutical
- Merck
- Zhejiang CONBA Pharmaceutical
- Henan Topfond
- Guangdong Eashu Pharmacetical
- RelonChem
- Dr. Reddy
- Cipla
- Actavis
- Accord Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Finasteride Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Finasteride Sales Estimates and Forecasts (2021-2032)
- 1.3 Finasteride Market by Type
- 1.3.1 1mg Tablet
- 1.3.2 5mg Tablet
- 1.4 Global Finasteride Market Size by Type
- 1.4.1 Global Finasteride Market Size Overview by Type (2021-2032)
- 1.4.2 Global Finasteride Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Finasteride Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Finasteride Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Finasteride Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Finasteride Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Finasteride Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Finasteride Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Finasteride Industry Trends
- 2.2 Finasteride Industry Drivers
- 2.3 Finasteride Industry Opportunities and Challenges
- 2.4 Finasteride Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Finasteride Revenue (2021-2026)
- 3.2 Global Top Players by Finasteride Sales (2021-2026)
- 3.3 Global Top Players by Finasteride Price (2021-2026)
- 3.4 Global Finasteride Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Finasteride Major Company Production Sites & Headquarters
- 3.6 Global Finasteride Company, Product Type & Application
- 3.7 Global Finasteride Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Finasteride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Finasteride Players Market Share by Revenue in 2025
- 3.8.3 2025 Finasteride Tier 1, Tier 2, and Tier 3
4 Finasteride Regional Status and Outlook
- 4.1 Global Finasteride Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Finasteride Historic Market Size by Region
- 4.2.1 Global Finasteride Sales in Volume by Region (2021-2026)
- 4.2.2 Global Finasteride Sales in Value by Region (2021-2026)
- 4.2.3 Global Finasteride Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Finasteride Forecasted Market Size by Region
- 4.3.1 Global Finasteride Sales in Volume by Region (2027-2032)
- 4.3.2 Global Finasteride Sales in Value by Region (2027-2032)
- 4.3.3 Global Finasteride Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Finasteride by Application
- 5.1 Finasteride Market by Application
- 5.1.1 Medical Uses
- 5.1.2 Application 2
- 5.2 Global Finasteride Market Size by Application
- 5.2.1 Global Finasteride Market Size Overview by Application (2021-2032)
- 5.2.2 Global Finasteride Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Finasteride Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Finasteride Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Finasteride Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Finasteride Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Finasteride Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Finasteride Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva Pharmaceuticals
- 6.1.1 Teva Pharmaceuticals Company Information
- 6.1.2 Teva Pharmaceuticals Business Overview
- 6.1.3 Teva Pharmaceuticals Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceuticals Finasteride Product Portfolio
- 6.1.5 Teva Pharmaceuticals Recent Developments
- 6.2 Sandoz
- 6.2.1 Sandoz Company Information
- 6.2.2 Sandoz Business Overview
- 6.2.3 Sandoz Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sandoz Finasteride Product Portfolio
- 6.2.5 Sandoz Recent Developments
- 6.3 Shandong Renhetang Pharmaceutical
- 6.3.1 Shandong Renhetang Pharmaceutical Company Information
- 6.3.2 Shandong Renhetang Pharmaceutical Business Overview
- 6.3.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shandong Renhetang Pharmaceutical Finasteride Product Portfolio
- 6.3.5 Shandong Renhetang Pharmaceutical Recent Developments
- 6.4 Merck
- 6.4.1 Merck Company Information
- 6.4.2 Merck Business Overview
- 6.4.3 Merck Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Merck Finasteride Product Portfolio
- 6.4.5 Merck Recent Developments
- 6.5 Zhejiang CONBA Pharmaceutical
- 6.5.1 Zhejiang CONBA Pharmaceutical Company Information
- 6.5.2 Zhejiang CONBA Pharmaceutical Business Overview
- 6.5.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio
- 6.5.5 Zhejiang CONBA Pharmaceutical Recent Developments
- 6.6 Henan Topfond
- 6.6.1 Henan Topfond Company Information
- 6.6.2 Henan Topfond Business Overview
- 6.6.3 Henan Topfond Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Henan Topfond Finasteride Product Portfolio
- 6.6.5 Henan Topfond Recent Developments
- 6.7 Guangdong Eashu Pharmacetical
- 6.7.1 Guangdong Eashu Pharmacetical Company Information
- 6.7.2 Guangdong Eashu Pharmacetical Business Overview
- 6.7.3 Guangdong Eashu Pharmacetical Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Guangdong Eashu Pharmacetical Finasteride Product Portfolio
- 6.7.5 Guangdong Eashu Pharmacetical Recent Developments
- 6.8 RelonChem
- 6.8.1 RelonChem Company Information
- 6.8.2 RelonChem Business Overview
- 6.8.3 RelonChem Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 RelonChem Finasteride Product Portfolio
- 6.8.5 RelonChem Recent Developments
- 6.9 Dr. Reddy
- 6.9.1 Dr. Reddy Company Information
- 6.9.2 Dr. Reddy Business Overview
- 6.9.3 Dr. Reddy Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Dr. Reddy Finasteride Product Portfolio
- 6.9.5 Dr. Reddy Recent Developments
- 6.10 Cipla
- 6.10.1 Cipla Company Information
- 6.10.2 Cipla Business Overview
- 6.10.3 Cipla Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Cipla Finasteride Product Portfolio
- 6.10.5 Cipla Recent Developments
- 6.11 Actavis
- 6.11.1 Actavis Company Information
- 6.11.2 Actavis Business Overview
- 6.11.3 Actavis Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Actavis Finasteride Product Portfolio
- 6.11.5 Actavis Recent Developments
- 6.12 Accord Pharmaceuticals
- 6.12.1 Accord Pharmaceuticals Company Information
- 6.12.2 Accord Pharmaceuticals Business Overview
- 6.12.3 Accord Pharmaceuticals Finasteride Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Accord Pharmaceuticals Finasteride Product Portfolio
- 6.12.5 Accord Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Finasteride Sales by Country
- 7.1.1 North America Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Finasteride Sales by Country (2021-2026)
- 7.1.3 North America Finasteride Sales Forecast by Country (2027-2032)
- 7.2 North America Finasteride Market Size by Country
- 7.2.1 North America Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Finasteride Market Size by Country (2021-2026)
- 7.2.3 North America Finasteride Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Finasteride Sales by Country
- 8.1.1 Europe Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Finasteride Sales by Country (2021-2026)
- 8.1.3 Europe Finasteride Sales Forecast by Country (2027-2032)
- 8.2 Europe Finasteride Market Size by Country
- 8.2.1 Europe Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Finasteride Market Size by Country (2021-2026)
- 8.2.3 Europe Finasteride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Finasteride Sales by Country
- 9.1.1 Asia-Pacific Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Finasteride Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Finasteride Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Finasteride Market Size by Country
- 9.2.1 Asia-Pacific Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Finasteride Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Finasteride Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Finasteride Sales by Country
- 10.1.1 South America Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Finasteride Sales by Country (2021-2026)
- 10.1.3 South America Finasteride Sales Forecast by Country (2027-2032)
- 10.2 South America Finasteride Market Size by Country
- 10.2.1 South America Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Finasteride Market Size by Country (2021-2026)
- 10.2.3 South America Finasteride Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Finasteride Sales by Country
- 11.1.1 Middle East and Africa Finasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Finasteride Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Finasteride Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Finasteride Market Size by Country
- 11.2.1 Middle East and Africa Finasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Finasteride Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Finasteride Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Finasteride Value Chain Analysis
- 12.1.1 Finasteride Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Finasteride Production Mode & Process
- 12.2 Finasteride Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Finasteride Distributors
- 12.2.3 Finasteride Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst